Uncovering Inequities in Alzheimer’s Disease Screening and Care
January 6, 2026 | AI, Alzhimers Education, Komodo, MAPS, RWE
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their recent joint initiative, which used AI-driven analysis of real-world data to map trends in AD care and reveal where key inequities persist.
While new treatments continue to emerge, significant gaps remain in who gets screened, tested, and treated. Many patients, particularly those in higher-risk groups, still do not receive timely or adequate care.
Key Findings
The analysis found gender-based screening rates reflect national underscreening patterns. The Centers for Disease Control and Prevention data shows only 47% of primary care physicians routinely assess cognitive function in patients age 65 years and older. Men and women are screened at similar rates, yet diagnosis rates differ sharply: 2,620 per 100,000 for females vs1,687 per 100,000 for males.
Racial disparities also surfaced. Black patients, who made up 10% of Alzheimer’s patients, accounted for only 3% of those treated with the second approved DMT, which suggests missed opportunities for earlier detection and intervention.
The Role of Education
Targeted education, including continuing medical education (CME), is a powerful mechanism for change. In a study evaluating a subset of independent medical education programs, clinicians who participated showed an increase in new AD diagnoses that was 1.6x greater than matched controls.1 Post-learning in confidence correlated with real-world behavior change, reinforcing confidence as an early predictor of improved practice.^1
The Growing Need for Action
Today, 7.2 million people in the United States are affected by Alzheimer’s disease, and this number is expected to rise to nearly 13 million by 2050. Globally, that figure is expected to reach 152 million. In this rapidly evolving landscape, clinician education will remain essential to improving awareness of emerging therapies, screening recommendations, and care pathways. As the leading provider of CME for healthcare professionals, Medscape will continue to drive educational initiatives that support earlier detection and more equitable care for all patients affected by AD.
To access the on-demand webinar please visit: https://medicalaffairs.org/webinar-harnessing-ai-and-real-world-evidence-to-advance-alzheimers-screening/
For a full scope on Medscape and Komodo’s Alzheimer’s research please visit: https://education.medscape.org/advancing-alzheimers-equitable-access-with-ai-rwe-maps
*Please note: The webinar is free for MAPS members, a fee for non-members.
About Medscape
Medscape is the leading clinical resource for physicians and healthcare professionals, delivering trusted medical news, evidence-based information, and point-of-care tools—now accelerated by AI. Serving specialists, primary care physicians, and the broader healthcare community, Medscape combines authoritative medical intelligence with powerful educational and clinical decision support tools. Medscape Education (medscape.org) is the premier destination for continuous professional development, offering 30+ specialty-focused channels with thousands of free CME and CE courses. Medscape is a subsidiary of WebMD Health Corp.
About Komodo Health
Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and machine learning to connect the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo helps its customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision-making, close gaps in care, address disease burden, and help enterprises create a more cost-effective, value-driven healthcare system. For more information, visit Komodohealth.com.
To see more articles like this, follow Komodo Health on X, LinkedIn, or YouTube, and visit Perspectives on their website. Follow Medscape Education on Xand LinkedIn.
For more information about this research, contact Katie Lucero, PhD, at Klucero@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education Global to Join Biotechs at Swiss Biotech Day
The Medscape Education Global team is excited to announce its participation in Swiss Biotech Day, taking place in Basel from May 5-6. This marks our inaugural attendance at this event,...
Gut Check: A Game-Changing Experience at DDW 2025 with Medscape!
The countdown is on! The Medscape team is heading to San Diego for this year’s highly anticipated Digestive Disease Week (DDW) conference—and you won’t want to miss what we’ve got...
Looking Ahead: Transparency, Impact, and Instructional Design at CMEpalooza Spring 2025
Tomorrow at 2 PM ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with Forward Thinking.” This session will spotlight how clear communication...
Vaccines Are the Most Impactful Innovation in Health Equity
As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from November 2024, childhood vaccination...
Collaboration Across Healthcare is the Path Forward
How do we impress upon women that they need to prioritize their own health before providing for the people who need them? A leader in medical oncology has a few...
Medscape at ESCMID 2025: Advancing Infectious Disease Education
Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With 1.47 million ID learners in 2024, the Medscape team will travel to...
The future of heart health with AI-powered devices and treatment approaches
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and...
Medscape at ACC 2025: From Taking the Pulse to Getting to the Heart of It
The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference, March 29-31, bringing an array of engaging educational booth highlights, interactive symposia, scientific posters, and more for...
Michelle Worst Honored With 2025 HOPA Volunteer Award
Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of...
Innovations in Women’s Health Coalition Launches New Global Efforts
Medscape Education, the leader in continuing medical education for healthcare professionals, is extending its commitment to closing gaps in women's health by expanding the efforts of its Innovations in Women's...